SABBY MANAGEMENT, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 7 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$618,000
-96.8%
44
-97.5%
0.09%
-97.8%
Q4 2018$19,054,000
-32.4%
1,7460.0%4.19%
+16.2%
Q3 2018$28,200,000
+0.8%
1,746
-17.5%
3.61%
-16.6%
Q2 2018$27,983,000
-19.1%
2,117
-54.6%
4.32%
+109.5%
Q1 2018$34,570,000
-31.1%
4,666
-48.3%
2.06%
-54.9%
Q4 2017$50,204,000
+52.4%
9,023
+24.2%
4.57%
+112.4%
Q3 2017$32,945,000
+73.1%
7,263
+28.6%
2.15%
+72.9%
Q2 2017$19,033,000
+58.8%
5,646
+39.4%
1.24%
+92.7%
Q1 2017$11,985,000
+615.1%
4,049
+562.7%
0.65%
+566.0%
Q4 2016$1,676,000
-92.3%
611
-82.7%
0.10%
-88.0%
Q3 2016$21,653,000
-25.4%
3,526
-76.8%
0.81%
-46.5%
Q2 2016$29,034,000
+1146.6%
15,225
+1176.2%
1.52%
+1194.9%
Q1 2016$2,329,000
-78.9%
1,193
-58.3%
0.12%
-80.7%
Q4 2015$11,042,000
-48.5%
2,862
-57.1%
0.61%
-31.3%
Q3 2015$21,421,000
+4.7%
6,671
-0.8%
0.88%
+18.4%
Q2 2015$20,458,000
+112.0%
6,723
-7.5%
0.75%
+85.6%
Q1 2015$9,651,000
+1.5%
7,267
+10.6%
0.40%
+34.0%
Q4 2014$9,510,000
+26.1%
6,572
+83.9%
0.30%
+3.4%
Q3 2014$7,541,000
+54.5%
3,574
+118.2%
0.29%
+38.8%
Q2 2014$4,880,000
+478.9%
1,638
+366.7%
0.21%
+344.7%
Q1 2014$843,000
-80.4%
351
-83.3%
0.05%
-82.8%
Q4 2013$4,292,000
-66.5%
2,107
-22.2%
0.27%
-67.1%
Q3 2013$12,795,000
+48.9%
2,709
+19.9%
0.83%
+44.9%
Q2 2013$8,595,0002,2590.57%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 124,000$11,468,0000.01%
JPMORGAN CHASE & CO 200,000$18,496,0000.00%
SIMPLEX TRADING, LLC 32,500$2,543,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders